Abstract
The uptake of [(9,10)-3H]hexadecylphosphocholine (HePC) in six tumor cell lines was studied. All cell lines incorporated HePC in similar amounts, with the exception of the epidermoid cancer cell line KB, which took up higher amounts of HePC. The uptake of HePC at 37°C was shown to be time and concentration dependent. At 20°C, uptake was drastically reduced and at 4°C it was blocked completely. Binding of HePC, at 4°C, was not saturable at concentrations between 5 βg/mL (11.8 μM) and 100 μg/mL (235.3 μM), indicating that cell surface binding is not receptor-mediated. Furthermore, the effects of inhibitors of endocytosis were investigated. We observed a pronounced inhibitory effect by monensin and cytochalasin B. Colchicine was somewhat less effective whereas chloroquine was almost without effect. From these data we conclude that uptake of HePC is most probably mediatedvia a receptor-independent endocytotic mechanism.
Similar content being viewed by others
Abbreviations
- ATP:
-
adenosine triphosphate
- FCS:
-
fetal calf serum
- HePC:
-
hexadecylphosphocholine
- NaSCN:
-
sodium thiocyanate
- NIM:
-
neutrophile isolation medium
References
Eibl, H., and Unger, C. (1986)J. Cancer Res. Clin. Oncol. (Suppl.) 22, 111.
Fleer, E.A.M., Unger, C., Kim, D.-J., and Eibl, H. (1987)Lipids 22, 856–861.
Unger, C., Fleer, E.A.M., Kötting, J., Neumüller, W., and Eibl, H. (1992) inProgress in Experimental Tumor Research (Unger, C., Hilgard, P., and Eibl, H., eds.) pp. 25–32, Karger Verlag, Basel.
Hilgard, P., Stekar, J., and Harleman, J.H. (1992) inProgress in Experimental Tumor Research (Unger, C., Hilgard P., and Eibl, H., eds.) pp. 116–130, Karger Verlag, Basel.
Muschiol, C., Berger, M.R., Schuler, B., Scherf, H.R., Garzon, F.T., Zeller, W.J., Unger, C., Eibl, H., and Schmaehl, D. (1986)Lipids 22, 930–934.
Unger, C., Eibl, H., Nagel, G.A., von Heyden, H.W., Breiser, A., Engel, J., Stekar, J., Peukert, M., Hilgard, P., and Berger, M. (1989)Contrib. Oncol. 37, 219–223.
Dummer, R., Röger, J., Vogt, T., Becker, J., Hefner, H., and Sindermann, H. (1992) inProgress in Experimental Tumor Research (Unger, C., Hilgard, P., and Eibl, H., eds.) pp. 160–169, Karger Verlag, Basel.
Ries, U.J., Fleer, E.A.M., Breiser, A., Unger, C., Stekar, J., Fenneberg, K., and Eibl, H. (1993)Eur. J. Cancer 29A, 96–101.
Überall, F., Oberhuber, K.M., Zaknun, J., Demuth, L., and Grunicke, H.H. (1991)Cancer Res. 51, 807–812.
Shoji, M., Raynor, R.L., Fleer, E.A., Eibl, H., Vogler, W.R., and Kuo, J.F. (1991)Lipids 26, 144–149.
Vehmeyer, K., Scheurich, P., Eibl, H., and Unger, C. (1991)Cellular Immunology 136, 232–234.
Hochhuth, C., Berkovic, D., Eibl, H., Unger, C., and Doenecke, D. (1990)J. Cancer Res. Clin. Oncol. 116, 456–466.
Vehmeyer, K., Eibl, H., and Unger, C. (1992)Exp. Hematology 20, 1–5.
Eibl, H., and Wooley, P. (1988)Chem. Phys. Lipids 47, 63–68.
Eibl, H., and Lands, W.E. (1969)Anal. Biochem. 30, 51–57.
Pulvertaft, R.J.V. (1964)Lancet 1, 238–240.
Hudson, L., and Hay, F.C. (1976) inPractical Immunology Blackwell Scientific Publications, pp. 29–32, Oxford.
Sale, F.O., Marchesini, S., Fishman, P.H., and Berra, B.A. (1984)Anal. Biochem. 145, 347–350.
Hanstein, W.G. (1976)TIBS 1, 65–67.
Kilbourne, E.D. (1959)Nature 183, 271–272.
Baumann, W.J., and Malewicz, B. (1986)Second International Conference on Platelet-Activating Factor and Structurally-Related Ether Lipids, Gatlinburg, TN, October 1986.
Kumar, V.V., and Baumann, W.J. (1986)Biochem. Biophys. Res. Commun. 139, 25–30.
Travers, J.B., Li, Q., Kniss, D.A., and Fertel, R.H. (1989)J. Immunol. 143, 3708–3713.
Hwang, S.-B., Lee, C.-S.C., Cheah, M.J., and Shen, T.Y. (1983)Biochemistry 22, 4756–4763.
Lehninger, A.L. (1970)Biochemistry, pp. 605–626, Worth Publishers, Inc., New York.
Abo, T., Sugawara, S., Amenomori, A., Itoh, H., Rikiishi, H., Moro, I., and Kumagai, K. (1986)J. Immunol. 136, 3189–3197.
Wolkoff, A.W., Klausner, R.D., Ashwell, G., and Harford, J. (1984)J. Cell Biol. 98, 375–381.
Chang, T.-M., and Kullberg, D.W. (1984)Biochim. Biophys. Acta 805, 268–276.
Unger, J., and Ketelbrant, P. (1998)Endocrinol. 123, 66–71.
Hedin, U., and Thyberg, J. (1985)Eur. J. Cell Biol. 39, 130–135.
Johnson, D.C., and Spear, P.G. (1992)J. Virol. 43, 1102–1112.
Poole, B., and Ohkuma, S. (1981)J. Cell Biol. 90, 665–669.
Walter, R.J., Berlin, R.D., Pfeiffer, J.R., and Oliver, J.M. (1980)J. Cell Biol. 86, 199–211.
Stenset, K., Hedin, U., and Thyberg, J. (1983)Eur. J. Cell Biol. 31, 15–25.
Storrie, B., Pool, Jr., R.R., Sachdeva, M., Maury, K.M., and Oliver, C. (1984)J. Cell Biol. 98, 108–115.
Thirion, J., and Wattiaux, R. (1988)Biochem. Biophys. Res. Commun. 152, 1275–1281.
Klopfenstein, W.E. (1986)Biochim. Biophys. Acta 181, 323–325.
Baisted, D.J., Robinson, B.S., and Vance, D.E. (1988)Biochem. J. 253, 693–701.
Sekas, G., Patton, G.M., Lincoln, E.C., and Robins, S.J. (1985)J. Lab. Clin. Med. 105, 190–194.
Robinson, B.S., Baisted, D.J., and Vance, D.E. (1989)Biochem. J. 264, 125–131.
Graham, A., Bennett, A.J., McLean, A.A.M., Zammit, V.A., and Brindley, D.N. (1988)Biochem. J. 253, 687–692.
Robinson, B.S., Yao, Z., Baisted, D.J., and Vance, D.E. (1989)Biochem. J. 260, 207–214.
Switzer, S., and Eder, H.A. (1965)J. Lipid Res. 6, 506–511.
Andreesen, R., Modelell, M., Oepke, G.H., Common, H., Lohr, G.W., and Munder, P.G. (1982)Anticancer Res. 2, 95–100.
Kötting, J., Marschner, N.W., Unger, C., and Eibl, H. (1992) inProgress in Experimental Tumor Research (Unger, C., Hilgard, P., and Eibl, H., eds.) pp. 6–11, Karger Verlag, Basel.
Bazill, G.W., and Dexter, T.M. (1990)Cancer Res. 50, 7505–7512.
Author information
Authors and Affiliations
About this article
Cite this article
Fleer, E.A.M., Berkovic, D., Eibl, H. et al. Investigations on the cellular uptake of hexadecylphosphocholine. Lipids 28, 731–736 (1993). https://doi.org/10.1007/BF02535995
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535995